Cargando…
Ivermectina en COVID-19. ¿Argumentum ad ignorantiam?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI).
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290213/ https://www.ncbi.nlm.nih.gov/pubmed/33994568 http://dx.doi.org/10.1016/j.rce.2020.06.003 |
| _version_ | 1783545624075960320 |
|---|---|
| author | Carlosama-Rosero, Y. |
| author_facet | Carlosama-Rosero, Y. |
| author_sort | Carlosama-Rosero, Y. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7290213 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI). |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72902132020-06-12 Ivermectina en COVID-19. ¿Argumentum ad ignorantiam? Carlosama-Rosero, Y. Rev Clin Esp Correspondencia Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI). 2020-10 2020-06-12 /pmc/articles/PMC7290213/ /pubmed/33994568 http://dx.doi.org/10.1016/j.rce.2020.06.003 Text en © 2020 Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI). All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondencia Carlosama-Rosero, Y. Ivermectina en COVID-19. ¿Argumentum ad ignorantiam? |
| title | Ivermectina en COVID-19. ¿Argumentum ad ignorantiam? |
| title_full | Ivermectina en COVID-19. ¿Argumentum ad ignorantiam? |
| title_fullStr | Ivermectina en COVID-19. ¿Argumentum ad ignorantiam? |
| title_full_unstemmed | Ivermectina en COVID-19. ¿Argumentum ad ignorantiam? |
| title_short | Ivermectina en COVID-19. ¿Argumentum ad ignorantiam? |
| title_sort | ivermectina en covid-19. ¿argumentum ad ignorantiam? |
| topic | Correspondencia |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290213/ https://www.ncbi.nlm.nih.gov/pubmed/33994568 http://dx.doi.org/10.1016/j.rce.2020.06.003 |
| work_keys_str_mv | AT carlosamaroseroy ivermectinaencovid19argumentumadignorantiam |